Brammer Biopharmaceuticals and Florida Biologix have joined forces to create a leading cell and gene therapy CDMO
(Based on 2014 Sales, in $U.S. Millions)
Highlights biopharma industry's growth drivers and new approaches for mitigating risk
Sign up now to receive the free weekly newsletter, and more!
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.